ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1698

X Chromosome DNA Methylation Changes Suggest Epigenetic Contributions to Immune Dysregulation in Male Lupus

Desire Casares Marfil1, Gülşah Kavrul Kayaalp2, Vafa Guliyeva2, Özlem Akgün2, Şeyma Türkmen3, Elif Kilic Konte4, Sezgin Sahin4, Ozgur Kasapcopur5, Betul Sozeri6, Selçuk Sözer Tokdemir7, Nuray Aktay Ayaz8 and Amr Sawalha1, 1University of Pittsburgh, Pittsburgh, PA, 2Istanbul University Faculty of Medicine, Istanbul, Turkey, 3University of Health Sciences, Umraniye Research and Training Hospital, Istanbul, Turkey, 4Istanbul University Cerrahpasa Medical School, Istanbul, Turkey, 5Istanbul University-Cerrahpasa, Cerrahpasa Medical School, istanbul, Turkey, 6Health sciences university, Istanbul, Turkey, 7Istanbul University, Istanbul, Turkey, 8Istanbul University Medical School, Istanbul, Turkey

Meeting: ACR Convergence 2025

Keywords: Epigenetics, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Genetics, Genomics & Proteomics (1698–1703)

Session Type: Abstract Session

Session Time: 3:00PM-3:15PM

Background/Purpose: DNA methylation plays a critical role in the pathogenesis of lupus. Although most epigenetic studies have focused on autosomal regions, the X chromosome remains underexplored. In this study, we investigate X chromosome DNA methylation patterns in male patients with lupus. Studying male individuals allows us to circumvent the analytical complexities posed by random X-inactivation in female patients with two X chromosomes, enabling a clearer view of epigenetic changes that may contribute to disease mechanisms.

Methods: A total of 16 male patients with childhood-onset lupus and 14 healthy male controls were included. DNA from peripheral blood mononuclear cells (PBMCs) was isolated to assess DNA methylation patterns using the Infinium MethylationEPIC v2.0 array (Illumina). Data processing and statistical analyses were conducted using the minfi and limma R packages. Group differences in methylation patterns were tested via linear regression, adjusting for age and estimated cell-type proportions. Gene ontology enrichment analysis was performed with Metascape.

Results: A total of 23,364 DNA methylation sites (CpGs) on the X chromosome were analyzed. Differential methylation analysis between cases and controls identified 1,120 CpG sites with suggestive associations (p < 0.05), mapping to 593 genes. Approximately half of these sites were hypomethylated in patients compared to controls, with several CpGs located in immune-related genes. Notably, several hypomethylated CpGs were found in genes involved in the toll-like receptor (TLR) signaling pathway, including TLR7, TASL, and BTK, which are key components of innate immune signaling pathways that drive the expression of pro-inflammatory cytokines. Pathway enrichment analysis of the top 100 most significant differentially methylated CpGs revealed overrepresentation of immune and regulatory pathways, such as positive regulation of type I interferon production, response to interleukin-1, and regulation of cellular response to growth factor stimulus, suggesting epigenetic remodeling of critical processes in disease pathogenesis.

Conclusion: These findings highlight previously underrecognized X chromosome DNA methylation changes in lupus, particularly in immune-related genes and pathways. Our results suggest that epigenetic dysregulation on the X chromosome may contribute to immune activation and disease pathogenesis, underscoring the importance of including sex chromosomes in lupus epigenetic studies.


Disclosures: D. Casares Marfil: None; G. Kavrul Kayaalp: None; V. Guliyeva: None; Ö. Akgün: None; Ş. Türkmen: None; E. Kilic Konte: None; S. Sahin: None; O. Kasapcopur: None; B. Sozeri: None; S. Sözer Tokdemir: None; N. Aktay Ayaz: None; A. Sawalha: None.

To cite this abstract in AMA style:

Casares Marfil D, Kavrul Kayaalp G, Guliyeva V, Akgün Ö, Türkmen Ş, Kilic Konte E, Sahin S, Kasapcopur O, Sozeri B, Sözer Tokdemir S, Aktay Ayaz N, Sawalha A. X Chromosome DNA Methylation Changes Suggest Epigenetic Contributions to Immune Dysregulation in Male Lupus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/x-chromosome-dna-methylation-changes-suggest-epigenetic-contributions-to-immune-dysregulation-in-male-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/x-chromosome-dna-methylation-changes-suggest-epigenetic-contributions-to-immune-dysregulation-in-male-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology